Manifestations driving relapse during rituximab treatment
| Manifestations driving relapse, mean relapses/person (% persons who suffered at least one relapse) | |
| Asthma/lung | 0.68±1.13 (43.5) |
| ENT | 0.17±0.38 (17.4) |
| Skin | 0.26±0.8 (13.0) |
| Kidney | 0 (0) |
| Heart | 0.03±0.169 (2.9) |
| Joint | 0.16±0.41 (14.5) |
| Digestive | 0.03±0.17 (2.9) |
| Neurological | 0.01±0.12 (1.4) |
ENT, ear, nose and throat.